Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 +1.95%62 5-Year Yield-on-Cost % is 7.39 as of Sep. 03, 2026, which is 39% above its 10-year median of 5.30. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,159.64 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, Olba DVx Healthcare ranks better than 89.86% on this metric.
Olba DVx Healthcare's yield on cost for the quarter that ended in Mar. 2026 was 7.39.
The historical rank and industry rank for Olba DVx Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:2689'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.06 Med: 5.3 Max: 7.79
Current: 7.39
During the past 13 years, Olba DVx Healthcare's highest Yield on Cost was 7.79. The lowest was 3.06. And the median was 5.30.
TSE:2689's 5-Year Yield-on-Cost % is ranked better than 89.86% of 69
companies
in the Medical Distribution industry
Industry Median: 3.14
vs TSE:2689: 7.39
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Olba DVx Healthcare 5-Year Yield-on-Cost % Related Terms
TSE:2689 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Olba DVx Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Olba DVx Healthcare (TSE:2689) has a 5-Year Yield-on-Cost % of 7.39 as of Sep. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Olba DVx Healthcare and its competitors. This is 39% above median its historical median of 5.30. Over the past decade, Olba DVx Healthcare's 5-Year Yield-on-Cost % has ranged from 3.06 to 7.79. According to the industry distribution chart, Olba DVx Healthcare ranks #7 out of 69 companies in the Medical Distribution industry, placing it in the top 10.1%.
Is Olba DVx Healthcare's 5-Year Yield-on-Cost % too high?
Olba DVx Healthcare's current 5-Year Yield-on-Cost % of 7.39 is 39% above median its 10-year median of 5.30. Over the past 10 years, this metric has ranged from a low of 3.06 to a high of 7.79. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.14. Olba DVx Healthcare's value of 7.39 is 135.4% above this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #7 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #7 out of 69 companies for 5-Year Yield-on-Cost %. This places Olba DVx Healthcare in the top 10% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.14. Olba DVx Healthcare's value of 7.39 is 135.4% above this benchmark. Historically, Olba DVx Healthcare's own 5-Year Yield-on-Cost % has ranged from 3.06 to 7.79 over the past decade. While the company's 10-year median is 5.30 vs. the industry median of 3.14, Olba DVx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.14, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current 5-Year Yield-on-Cost % of 7.39 is 135.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current 5-Year Yield-on-Cost % is 7.39, which is 39% above median its own 10-year median of 5.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,159.64, compared to a current price of 円1,932.00 — trading 10.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 7.39, which is 39% above median its 10-year median of 5.30 and 135.4% above the Medical Distribution industry median of 3.14. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current 5-Year Yield-on-Cost % is 7.39 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,932.00 is trading 10.5% below its estimated GF Value™ of 円2,159.64.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
5-Year Yield-on-Cost %: 7.39 (39% above median its 10-year median of 5.30)
GF Value™: 円2,159.64 vs. price of 円1,932.00 (10.5% below fair value)
Industry Position: 135.4% above the Medical Distribution median (#7 of 69)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
